pharma

CVS Beats Q3 Estimates but Shares Slip

CVS Beats Q3 Estimates but Shares Slip

CVS Health Corp. (NYSE:CVS) reported its third quarter earnings and beat analysts’ estimates, but shares fell by over 3 percent early shortly after open on Monday.For the third quarter, CVS reported revenue of $46.18 billion, increasing 3.5 pe..

Novartis buys Advanced Accelerator Applications for $3.9 billion

Novartis buys Advanced Accelerator Applications for $3.9 billion

Novartis AG (NYSE: NVS) has entered into a written agreement with French pharmaceutical company, Advanced Accelerator Applications (NASDAQ: AAAP), for $3.9 billion. Novartis shares were up 0.8 percent and Advanced Accelerator Applications shares wer..

Abbott Laboratories Announced Better-than-Expected Q3 Results

Abbott Laboratories Announced Better-than-Expected Q3 Results

On Wednesday, Abbott Laboratories (NYSE: ABT) announced its financial results for the third quarter of 2017, with both earnings and revenue beating estimates. Shares of the company increased 1.6% in morning trade on Wednesday.According to the compan..

Spectrum shares surge on positive results from lung cancer treatment trial

Spectrum shares surge on positive results from lung cancer treatment trial

Spectrum Pharmaceutical Inc. (NASDAQ: SPPI) shares surged over 40 percent on Tuesday at open after its announcement of positive results from its Phase 2 clinical study of poziotinib. The announcement was presented at the 18th IASLC World Conference ..

Johnson & Johnson's Q3 Earnings Drop but Beat Estimates

Johnson & Johnson's Q3 Earnings Drop but Beat Estimates

On Tuesday, Johnson & Johnson (NYSE: JNJ) announced its financial results for the third quarter of 2017. The company also adjusted its guidance for full-year 2017 in the statement on Tuesday.For the third quarter of 2017, the company announced s..

National Institute of Health partners with 11 Biopharma companies for Cancer Research

National Institute of Health partners with 11 Biopharma companies for Cancer Research

The National Institutes of Health and 11 biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT). This is a five-year-public-private research collaboration totaling $215 million as part of the Cancer Moons..

Pfizer Considers the Sales of its Consumer Healthcare Business

Pfizer Considers the Sales of its Consumer Healthcare Business

On Tuesday, Pfizer Inc. (NYSE: PFE), the pharmaceutical giant, said that it is considering the sale or spin-off of its consumer healthcare business, whose brands include lip balm Chapstick and painkiller Advil.The company’s consumer healthcare..